Inhaler Trainer Efficacy Study (NCT06461403) | Clinical Trial Compass
CompletedNot Applicable
Inhaler Trainer Efficacy Study
United States10 participantsStarted 2025-10-09
Plain-language summary
This will be a randomized, controlled, clinical trial. The investigators aim to determine the feasibility of and efficacy of the Inhaler Trainer Device for ongoing inhaler skill training.
The research team will enroll 140 patients from the inpatient or outpatient setting from the University of Chicago Medicine over the course of up to 12 months. Participants will complete assessments, a lung function test via spirometry, and inhaler education via either the Inhaler Trainer Device learning program or Brief Intervention.
All participants will return at 6 weeks (window of +/- one week) post-initial inhaler education for an in-person evaluation of their inhaler skills, lung function, and acute care utilization. Finally, a post-study semi-structured interview will be conducted to gather feedback on the device after the 6-week visit has been completed.
Who can participate
Age range
18 Years – 85 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Serevent®Diskus®(GSK), Salmeterol
. Incruse Ellipta (GSK), Umeclidinium
. Spiriva Handihaler (BIP),Tiotropium
. Tudorza Pressair (AstraZeneca), Aclidinium
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This study focused on inhaler technique training — do you think my current inhaler technique is good enough, or could I benefit from a similar kind of structured trainer assessment like the one used in this trial?
2Since this trial has already been completed, have the results shown that using an inhaler trainer device actually leads to measurable improvements in technique for people with asthma or COPD, and could those findings change how you'd teach me to use my inhaler?
3The study was specifically designed to assess inhaler technique — are there common mistakes people with my condition make when using their inhaler that I might not even be aware of, and how would we catch them?
4Given that this was a non-drug study focused on education and technique rather than a new medication, would you recommend I go through a formal inhaler technique review as part of my current treatment plan, regardless of this trial?
5If my inhaler technique has been contributing to poor symptom control, would correcting it potentially reduce my risk of an acute exacerbation, and is that something we should prioritize before considering any changes to my medication?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.